Efficacy and Safety of Autologous Peptide-induced Active Immunity in AML Maintenance Therapy

Clinical trial NCT07551037 · RECRUITING

Trial details

NCT number: NCT07551037
Sponsor: Fujian Medical University Union Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Personalized Active Immunotherapy Maintenance Therapy

Start date: 2024-09-01
Primary completion: 2026-09-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.